View Future GrowthBlack Hawk Acquisition 過去の業績過去 基準チェック /16Black Hawk Acquisitionの収益は年平均-68.9%で減少しているが、Capital Markets業界はgrowingで6.1%年平均の収益となった。主要情報-68.87%収益成長率-54.34%EPS成長率Capital Markets 業界の成長10.26%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報28 Feb 2026最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Apr 16Black Hawk Acquisition Corporation announced delayed 10-Q filingOn 04/14/2026, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 03Black Hawk Acquisition Corp Receives Non-Compliance Notice from the Nasdaq Stock Market LLCOn March 31, 2026, Black Hawk Acquisition Corporation (the Company) received a notice (the MVLS Notice) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) stating that the Company's market value of listed securities (MVLS) for the last 30 consecutive business days was less than the $50,000,000 required for continued listing on the Nasdaq Global Market under Listing Rule 5450(b)(2)(A) (the MVLS Requirement). The Company has a period of 180 calendar days, or until September 28, 2026 (the MVLS Compliance Date), to regain compliance with the MVLS Requirement. To regain compliance with the MVLS Requirement, the Company's MVLS must close at $50,000,000 or more for a minimum period of ten consecutive business days. Nasdaq may, in its discretion, require the Company to maintain the minimum MVLS for a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance. In the event the Company does not regain compliance with the MVLS Requirement prior to the MVLS Compliance Date, the Company will receive written notification that the Company's securities are subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq Listing Qualifications Panel, but there can be no assurance that the panel would grant the Company's request for continued listing. Alternatively, the Company may consider applying to transfer the listing of the Company's securities to the Nasdaq Capital Market (the Capital Market), provided that the Company then satisfies the requirements for continued listing on that market. The Company is monitoring the MVLS of its listed securities and is considering available options to regain compliance with Nasdaq's continued listing standards. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A) or maintain compliance with other applicable Nasdaq listing requirements. The Notice does not result in the immediate delisting of the Company's class A Ordinary Shares, and the Company's Units, Rights, and Class A Ordinary Shares, will continue to trade uninterrupted on the Nasdaq Global Market under the symbols BKHAU, BKHAR, and BKHA, respectively.お知らせ • Mar 03Black Hawk Acquisition Corporation announced delayed annual 10-K filingOn 03/02/2026, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Oct 16Black Hawk Acquisition Corporation announced delayed 10-Q filingOn 10/15/2025, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 07Black Hawk Acquisition Corporation Announces Committee and Board ChangesOn April 29, 2025, Black Hawk Acquisition Corporation reported the death of Brandon Miller, a member of the Company’s board of directors and the Chairperson of the Audit Committee. On April 29, 2025, the Board appointed Daniel M. McCabe, a current member of the Board and the then Chairperson of the Compensation Committee, to serve as Chairperson of the Audit Committee. On the same day, Mr. McCabe resigned from his position as Chairperson of the Compensation Committee, and the Board appointed Terry W. Protto, a current member of the Board, to serve as Chairperson of the Compensation Committee.お知らせ • Apr 29Vesicor Therapeutics, Inc. entered into a business combination agreement to acquire Black Hawk Acquisition Corporation (NasdaqGM:BKHA) in a reverse merger transaction for $70 million.Vesicor Therapeutics, Inc. entered into a business combination agreement to acquire Black Hawk Acquisition Corporation (NasdaqGM:BKHA) in a reverse merger transaction for $70 million on April 26, 2025. The Transaction values Vesicor at a pre-money equity value of $70 million. Under the terms of the merge with Vesicor, resulting in Vesicor being the wholly owned subsidiary of Black Hawk, who will continue to be the listed company on the Nasdaq Stock Market and change its name to Vesicor Therapeutics. The Transaction, which has been approved unanimously by the boards of directors of both Black Hawk and Vesicor, is subject to regulatory approvals, the approvals by the shareholders of Black Hawk and Vesicor, respectively, and the satisfaction of certain other customary closing conditions, including, among others, a Form S-4 registration statement under the Securities Act of 1933, of which the proxy statement/prospectus forms a part, being declared effective by the U.S. Securities and Exchange Commission (the “SEC”), and the approval by Nasdaq of the listing application of the combined company. The Business Combination is expected to be completed by the fourth quarter of 2025. Celine & Partners, PLLC acted as legal advisor for Black Hawk Acquisition Corporation. Ogier Global Limited acted as legal advisor for Black Hawk Acquisition Corporation. PW Richter plc acted as legal advisor for Vesicor Therapeutics, Inc.収支内訳Black Hawk Acquisition の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqGM:BKHA 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費28 Feb 26011030 Nov 25011031 Aug 25021031 May 25031028 Feb 25031030 Nov 240210質の高い収益: BKHAは 高品質の収益 を持っています。利益率の向上: BKHAの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BKHAの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: BKHAは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: BKHAは過去 1 年間で収益成長率がマイナス ( -68.9% ) となったため、 Capital Markets業界平均 ( 38.3% ) と比較することが困難です。株主資本利益率高いROE: BKHAの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/16 14:59終値2026/06/16 00:00収益2026/02/28年間収益2025/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Black Hawk Acquisition Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 16Black Hawk Acquisition Corporation announced delayed 10-Q filingOn 04/14/2026, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 03Black Hawk Acquisition Corp Receives Non-Compliance Notice from the Nasdaq Stock Market LLCOn March 31, 2026, Black Hawk Acquisition Corporation (the Company) received a notice (the MVLS Notice) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) stating that the Company's market value of listed securities (MVLS) for the last 30 consecutive business days was less than the $50,000,000 required for continued listing on the Nasdaq Global Market under Listing Rule 5450(b)(2)(A) (the MVLS Requirement). The Company has a period of 180 calendar days, or until September 28, 2026 (the MVLS Compliance Date), to regain compliance with the MVLS Requirement. To regain compliance with the MVLS Requirement, the Company's MVLS must close at $50,000,000 or more for a minimum period of ten consecutive business days. Nasdaq may, in its discretion, require the Company to maintain the minimum MVLS for a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance. In the event the Company does not regain compliance with the MVLS Requirement prior to the MVLS Compliance Date, the Company will receive written notification that the Company's securities are subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq Listing Qualifications Panel, but there can be no assurance that the panel would grant the Company's request for continued listing. Alternatively, the Company may consider applying to transfer the listing of the Company's securities to the Nasdaq Capital Market (the Capital Market), provided that the Company then satisfies the requirements for continued listing on that market. The Company is monitoring the MVLS of its listed securities and is considering available options to regain compliance with Nasdaq's continued listing standards. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A) or maintain compliance with other applicable Nasdaq listing requirements. The Notice does not result in the immediate delisting of the Company's class A Ordinary Shares, and the Company's Units, Rights, and Class A Ordinary Shares, will continue to trade uninterrupted on the Nasdaq Global Market under the symbols BKHAU, BKHAR, and BKHA, respectively.
お知らせ • Mar 03Black Hawk Acquisition Corporation announced delayed annual 10-K filingOn 03/02/2026, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Oct 16Black Hawk Acquisition Corporation announced delayed 10-Q filingOn 10/15/2025, Black Hawk Acquisition Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 07Black Hawk Acquisition Corporation Announces Committee and Board ChangesOn April 29, 2025, Black Hawk Acquisition Corporation reported the death of Brandon Miller, a member of the Company’s board of directors and the Chairperson of the Audit Committee. On April 29, 2025, the Board appointed Daniel M. McCabe, a current member of the Board and the then Chairperson of the Compensation Committee, to serve as Chairperson of the Audit Committee. On the same day, Mr. McCabe resigned from his position as Chairperson of the Compensation Committee, and the Board appointed Terry W. Protto, a current member of the Board, to serve as Chairperson of the Compensation Committee.
お知らせ • Apr 29Vesicor Therapeutics, Inc. entered into a business combination agreement to acquire Black Hawk Acquisition Corporation (NasdaqGM:BKHA) in a reverse merger transaction for $70 million.Vesicor Therapeutics, Inc. entered into a business combination agreement to acquire Black Hawk Acquisition Corporation (NasdaqGM:BKHA) in a reverse merger transaction for $70 million on April 26, 2025. The Transaction values Vesicor at a pre-money equity value of $70 million. Under the terms of the merge with Vesicor, resulting in Vesicor being the wholly owned subsidiary of Black Hawk, who will continue to be the listed company on the Nasdaq Stock Market and change its name to Vesicor Therapeutics. The Transaction, which has been approved unanimously by the boards of directors of both Black Hawk and Vesicor, is subject to regulatory approvals, the approvals by the shareholders of Black Hawk and Vesicor, respectively, and the satisfaction of certain other customary closing conditions, including, among others, a Form S-4 registration statement under the Securities Act of 1933, of which the proxy statement/prospectus forms a part, being declared effective by the U.S. Securities and Exchange Commission (the “SEC”), and the approval by Nasdaq of the listing application of the combined company. The Business Combination is expected to be completed by the fourth quarter of 2025. Celine & Partners, PLLC acted as legal advisor for Black Hawk Acquisition Corporation. Ogier Global Limited acted as legal advisor for Black Hawk Acquisition Corporation. PW Richter plc acted as legal advisor for Vesicor Therapeutics, Inc.